Digi.Bio is a startup based in the Netherlands. Brouky records 1 investor associated with the company.
Digi.Bio develops technology for digital nucleic acid diagnostics, enabling rapid and sensitive molecular testing on portable devices.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.